(ROL) Rollins - Overview
Sector: Consumer Cyclical | Industry: Personal Services | Exchange: NYSE (USA) | Market Cap: 25.431m USD | Total Return: -4.1% in 12m
Industry Rotation: +1.2
Avg Turnover: 154M
EPS Trend: 60.9%
Qual. Beats: 0
Rev. Trend: 81.9%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Rollins, Inc. is a global provider of pest and wildlife control services, serving both residential and commercial sectors through a network of subsidiaries and franchises. Headquartered in Atlanta, the company manages a diverse portfolio of services including rodent and insect control, termite protection, and specialized workplace solutions for industries such as healthcare and logistics.
The pest control industry is characterized by highly recurring revenue streams, as services are typically performed on a monthly or quarterly basis to ensure long-term mitigation. The business model benefits from defensive demand characteristics, as pest management is often viewed as a non-discretionary expense for property maintenance and regulatory compliance.
Investors can further evaluate these industry dynamics and company fundamentals on ValueRay.
- Strategic acquisitions of regional pest control providers accelerate market share expansion
- Residential and commercial contract renewals maintain high recurring revenue stability
- Warming global temperatures increase pest activity and drive service demand volume
- Labor cost inflation and technician retention rates impact operational profit margins
- Expansion of high-margin ancillary services like wildlife control boosts average ticket value
| Net Income: 529.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA -0.69 > 1.0 |
| NWC/Revenue: -7.31% < 20% (prev -2.82%; Δ -4.49% < -1%) |
| CFO/TA 0.21 > 3% & CFO 649.6m > Net Income 529.3m |
| Net Debt (950.6m) to EBITDA (859.5m): 1.11 < 3 |
| Current Ratio: 0.65 > 1.5 & < 3 |
| Outstanding Shares: last quarter (481.4m) vs 12m ago -0.63% < -2% |
| Gross Margin: 51.78% > 18% (prev 0.53%; Δ 5.13k% > 0.5%) |
| Asset Turnover: 125.9% > 50% (prev 117.4%; Δ 8.44% > 0%) |
| Interest Coverage Ratio: 23.14 > 6 (EBITDA TTM 859.5m / Interest Expense TTM 31.6m) |
| A: -0.09 (Total Current Assets 513.7m - Total Current Liabilities 794.7m) / Total Assets 3.16b |
| B: 0.28 (Retained Earnings 900.2m / Total Assets 3.16b) |
| C: 0.24 (EBIT TTM 731.4m / Avg Total Assets 3.05b) |
| D: 0.78 (Book Value of Equity 1.38b / Total Liabilities 1.78b) |
| Altman-Z'' Score: 2.77 = A |
| DSRI: 0.81 (Receivables 210.7m/233.0m, Revenue 3.84b/3.46b) |
| GMI: 1.02 (GM 51.78% / 52.70%) |
| AQI: 1.06 (AQ_t 0.67 / AQ_t-1 0.63) |
| SGI: 1.11 (Revenue 3.84b / 3.46b) |
| TATA: -0.04 (NI 529.3m - CFO 649.6m) / TA 3.16b) |
| Beneish M-Score: -3.09 (Cap -4..+1) = AA |
Over the past week, the price has changed by -0.42%, over one month by -1.43%, over three months by -10.51% and over the past year by -4.06%.
- StrongBuy: 2
- Buy: 2
- Hold: 7
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 64.3 | 20.3% |
P/E Forward = 43.1034
P/S = 6.6141
P/B = 18.7576
P/EG = 3.8796
Revenue TTM = 3.84b USD
EBIT TTM = 731.4m USD
EBITDA TTM = 859.5m USD
Long Term Debt = 486.6m USD (from longTermDebt, last quarter)
Short Term Debt = 300.6m USD (from shortTermDebt, last quarter)
Debt = 1.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 950.6m USD (from netDebt column, last quarter)
Enterprise Value = 26.38b USD (25.43b + Debt 1.07b - CCE 116.5m)
Interest Coverage Ratio = 23.14 (Ebit TTM 731.4m / Interest Expense TTM 31.6m)
EV/FCF = 42.47x (Enterprise Value 26.38b / FCF TTM 621.1m)
FCF Yield = 2.35% (FCF TTM 621.1m / Enterprise Value 26.38b)
FCF Margin = 16.15% (FCF TTM 621.1m / Revenue TTM 3.84b)
Net Margin = 13.77% (Net Income TTM 529.3m / Revenue TTM 3.84b)
Gross Margin = 51.78% ((Revenue TTM 3.84b - Cost of Revenue TTM 1.85b) / Revenue TTM)
Gross Margin QoQ = 50.85% (prev 47.52%)
Tobins Q-Ratio = 8.35 (Enterprise Value 26.38b / Total Assets 3.16b)
Interest Expense / Debt = 0.83% (Interest Expense 8.85m / Debt 1.07b)
Taxrate = 21.34% (29.3m / 137.1m)
NOPAT = 575.3m (EBIT 731.4m * (1 - 21.34%))
Current Ratio = 0.65 (Total Current Assets 513.7m / Total Current Liabilities 794.7m)
Debt / Equity = 0.77 (Debt 1.07b / totalStockholderEquity, last quarter 1.38b)
Debt / EBITDA = 1.11 (Net Debt 950.6m / EBITDA 859.5m)
Debt / FCF = 1.53 (Net Debt 950.6m / FCF TTM 621.1m)
Total Stockholder Equity = 1.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 17.33% (Net Income 529.3m / Total Assets 3.16b)
RoE = 36.94% (Net Income TTM 529.3m / Total Stockholder Equity 1.43b)
RoCE = 38.10% (EBIT 731.4m / Capital Employed (Equity 1.43b + L.T.Debt 486.6m))
RoIC = 28.68% (NOPAT 575.3m / Invested Capital 2.01b)
WACC = 6.22% (E(25.43b)/V(26.50b) * Re(6.45%) + D(1.07b)/V(26.50b) * Rd(0.83%) * (1-Tc(0.21)))
Discount Rate = 6.45% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: 11.11 | Cagr: -0.25%
[DCF] Terminal Value 86.60% ; FCFF base≈612.7m ; Y1≈689.6m ; Y5≈926.7m
[DCF] Fair Price = 50.67 (EV 25.35b - Net Debt 950.6m = Equity 24.40b / Shares 481.5m; r=6.22% [WACC]; 5y FCF grow 14.57% → 3.0% )
EPS Correlation: 60.91 | EPS CAGR: 4.98% | SUE: 0.30 | # QB: 0
Revenue Correlation: 81.89 | Revenue CAGR: 6.57% | SUE: 1.33 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.34 | Chg30d=-0.15% | Revisions=-43% | Analysts=14
EPS next Quarter (2026-09-30): EPS=0.39 | Chg30d=+0.83% | Revisions=+0% | Analysts=13
EPS current Year (2026-12-31): EPS=1.25 | Chg30d=-0.11% | Revisions=-8% | GrowthEPS=+11.3% | GrowthRev=+9.7%
EPS next Year (2027-12-31): EPS=1.40 | Chg30d=-0.24% | Revisions=-14% | GrowthEPS=+11.9% | GrowthRev=+8.8%
[Analyst] Revisions Ratio: -43%